<?xml version="1.0" encoding="utf-8"?>
<Journal>
<Journal-Info>
<name>International Journal of Pharma and Bio Sciences</name>
<website>ijpbs.net</website>
<email>editorijpbs@rediffmail.com (or) editorofijpbs@yahoo.com (or) prasmol@rediffmail.com</email>
</Journal-Info>
<article>
<article-id pub-id-type='other'>10.22376/ijpbs.2019.10.1.p1-12</article-id>
<issue_number>Volume 9 Issue 2</issue_number>
<issue_period>2018 (April-June)</issue_period>
<title><b>Recent progress on anti-cancer of amide appended </b><b>heterocyclic and its possible therapeutic applications. A </b><b>review drug progress for cancer therapeutics. (Funded work)</b></title>
<abstract>Cancer is caused by malignant neoplasm related to unregulated cell growth. Neoplastic cells often reside in distinctive tumor hypoxia armed with a series of adaptive responses including oxidative stress, defective apoptotic machinery and neoangiogenesis, through that further confer cell survival improvement. There is a major unmet medical need for effective and well tolerated treatment options for cancer. The search now seeks to identify active biomolecules with multiple targets.This study has shown ambivalent results causing a prolonged over the value of drug and paving the way for the medicinal chemistry investigations of thiazole, pyridazine and pyrone analogues. Thiazole, pyridazine and pyrones nuclei show a broad spectrum of pharmaceutical applications. Thus, in this article, we have taken a step to review the evidences for cancer treatment, as well as to discuss the possible factors limiting the effectiveness of anti-cancer agents and to offer a recommendation for the future research of budding scientists on these therapies for the treatment of cancer has been taken.</abstract>
<authors>YASSER HUSSEIN EISSA MOHAMMED, SHAUKATH ARA KHANUM</authors>
<keywords>Anticancer; Malignant; Thiazole; Pyridazine; Neoplastic.</keywords>
<pages>94-124</pages>
</article>
</Journal>
